Druggio Logo

Druggio

Nippon Kayaku

Nippon Kayaku is a pharmaceutical company founded in 1916, with a focus on developing and manufacturing a wide range of drugs and pharmaceutical products. The company's portfolio includes medications for the treatment of various diseases, with a particular emphasis on oncology, ophthalmology, and inflammatory disorders. Nippon Kayaku is known for its commitment to research and development, aiming to bring innovative therapies to patients in need.

Nippon Kayaku's Drugs

Cetrotide

Approval date

2006/4/20

Immucyst

Approval date

2002/10/8

Evoxac, Saligren

Approval date

2001/6/20